International Journal of Technology Assessment in Health Care 1994: Vol 10 Index

7 Pages·1994·1.5 MB·English

Vol. 10 1994
International Jo
TECHNOLOGY
ASSESSMENT
IN HEALTH CARE
CAMBRIDGE
Published by the Press Syndicate of the University of Cambridge
The Edinburgh Building, Shaftsbury Road, Cambridge CB2 2RU
40 West 20th Street, New York, NY 10011, USA
10 Stamford Road, Oakleigh, Melbourne 3166, Australia
© Copyright 1994 by Cambridge University Press
Printed in the United States of America
CAMBRIDGE
UNIVERSITY PRESS
Printed in the United States of America
VOLUME 10 (1994) INDEX
Ada, Gordon. Desirable Immunologic Characteristics for the Development of an Ideal Vaccine, 71
Alford, Raye Lynn, Belinda J.F. Rossiter, C. Thomas Caskey. DNA Diagnosis in Monogenic Diseases, 628
Allison, Anthony C. Adjuvants and Immune Enhancement, 107
Alonso, Maria J. See Cohen
Amstey, Marvin. See Insel
Arita, Isao. See Robbins
Babazono, Akira, and Alan L. Hillman. A Comparison of International Health Outcomes and Health
Care Spending, 376
Biancamano, John. See Stetler
Bobrow, Martin. See Chitty
Booth, Holly. See Gillis
Brennan, Patricia Flatley, and Stefan Ripich. Use of a Home-Care Computer Network by Persons with
AIDS, 258
Brown, Fred. DNA Technology and Vaccines, 583
Brown, Fred. Synthetic Peptides and Purified Antigens as Vaccines, 161
Brown, Kenneth R., and R. Gordon Douglas, Jr. New Challenges in Quality Control and Licensure:
Regulation, 55
Buckingham, Ken, Ian Russell, Iain Ross, Patrick Gibson, and Neil Paterson. The Effect of Allowing
Clinical Discretion in Ordering Biochemical Tests: Evaluation by Complementary Methods, 695
Carrasco, Peter. See de Quadros
Caskey, Thomas C. See Alford
Chitty, Lyn S., and Martin Bobrow. Techniques in Current Use in Prenatal Diagnosis, 604
Cohen, Smadar, Robert Langer, and Maria J. Alonso. Novel Approaches to Controlled-Release Antigen
Delivery, 121
Cook, Sarah Sheets. Nurses and Technology: Maintaining a Balance Between Intervention and Nurturing
for Childbearing Women. A Commentary on Dr. Inger Stauning, 282
Curry, Stephen. See Stetler
Demicheli, Vittorio. See Jefferson
de Quadros, Ciro A., Jean-Marc Olivé, and Peter Carrasco. The Desired Field-Performance Characteristics
of New Improved Vaccines for the Developing World, 65
Douglas, R. Gordon, Jr. See Brown
Douglas, R. Gordon, Jr. See Ellis
Ellis, Ronald W., and R. Gordon Douglas, Jr. Combination Vaccines, 185
Eisenberg, John M. See Shimbo
Fagan, John. See Stetler
Fehlauer, Charles S. See Gillis
Feldman, Eric A. Culture, Conflict, and Cost: Perspectives on Brain Death in Japan, 447
Fischbein, Siv. See Furu
Ford, Leslie. See Kaluzny
Freeman, Phyllis. See Martinez-Palomo
Freeman, Phyllis, and Anthony Robbins. Introduction: Vaccine Technologies and Public Health: Why
a Critical Review Now?, 1
Freidman, Leonard H., and Jane Jorgensen. Physicians’ Influence on the Decision to Acquire Magnetic
Resonance Imagers in Acute Care Hospitals, 667
Fukushima, Masanori. See Ochiai
Furu, Margareta, Siv Fischbein, and Urban Rosengqvist. Individual Perception of Education and Treatment
Versus Actual Outcome: A Theoretical Model Exemplified by an Interventional Study on Patients with
Insulin-Dependent Diabetes Mellitus, 701
Galjaard, Hans. Genetic Technology in Health Care: A Global View, 527
Germain, Ronald N. Modern Concepts in Immune Recognition and Lymphocyte Activation: Relevance
for the Development of Useful Vaccines, 81
Gibson, Patrick. See Buckingham
Gillis, Pamela A., Charles S. Fehlauer, Holly Booth, Jerome Soller, and Judith R. Graves. Translating
Traditional Principles of System Development Into a Process for Designing Clinical Information
Systems, 235
Glick, Henry A. See Shimbo
Index
Goodman, Gerald R. Increasing Physician Acceptance of Technology Assessment Through a Focused
Training Program, 312
Graves, Judith R. See Gillis
Hanson, Monica. See Stetler
Hart, Gary L. See Rosenblatt
Hellsten, Gideon. See Lindholm
Hill, Terrel. See Parker
Hillman, Alan L. See Babazono
Hisashige, Akinori. Health Economic Analysis of the Neonatal Screening Program in Japan, 382
Hisashige, Akinori. The Introduction and Evaluation of MRI in Japan, 392
Hisashige, Akinori. See Ikegami
Holtzman, Neil A. Discovery, Transfer, and Diffusion of Technologies for the Detection of Genetic
Disorders: Policy Implications, 562
Homma, Akira, and Robert F. Knouss. The Transfer of Vaccine Technology to Developing Countries:
The Latin American Experience, 47
Insel, Richard A., Kathleen Woodin, Marvin Amstey, and Michael Pichichero. Maternal Immunization
to Prevent Infectious Diseases in the Neonate or Infant, 143
Ikeda, Shunya, Nobuaki Tsuchihashi, Nobuko Kawashiro, and Jin Kanzaki. Management of Acute Otitis
Media: Assessment of Therapeutic Strategy in Japan Today, 426
Ikegami, Naoki, and Akinori Hisashige. Introduction, 341
Jefferson, Tom, David Wright, and Vittorio Demicheli. An Economic Evaluation of the Introduction
of Vaccination Against Hepatitis A in a Peacekeeping Operation: The Case of the United Nations
Protection Force in Yugoslavia (UNPROFOR), 490
Jendteg, Stefan. See Wallengren
Jorgensen, Jane. See Freidman
Kaback, Michael M. Perspectives in Genetic Screening: Principles and Implications, 592
Kaluzny, Arnold D., Linda M. Lacey, Richard Warnecke, Joseph P. Morrissey, Edward J. Sondik, and
Leslie Ford. Accrual of Patients to Randomized Clinical Trials: Factors Affecting Cancer Prevention
and Control Research, 506
Kanemune, Miyuki. See Kitai
Kanzaki, Jin. See Ikeda
Karlsson, Ingela. See Larsson
Kawashiro, Nobuko. See Ikeda
Kitai, Hirokatsu, Hisako Watanabe, Mitsuko Sayama, Miyuki Kanemune, Mayumi Nishiyama, Ruriko
Nishino, and Kimihiko Itoh. The Acceptability of Prenatal Diagnosis in Japan, 436
Kiyono, Hiroshi. See McGhee
Knouss, Robert F. See Homma
Lacey, Linda M. See Kaluzny
La Montagne, John R., and N. Regina Rabinovich. The Promise of New Technologies, 7
Langer, Robert. See Cohen
Larson, Eric H. See Rosenblatt
Larsson, Par A., Gésta Pettersson, Anders MOller, Eva Berglin William-Olsson, Ingela Karlsson, Peter
A. Shapiro, and Marie Stolz-Léfgren. Toward a Model for Quality Assessment in Heart
Transplantation, 305
Lawton, Alexander R. Immunization of the Neonate, 154
Lemon, Stanley M., and Julie B. Milstien. The Thermostability of Vaccines: Technologies for Improving
the Thermostability of the Oral Poliovirus Vaccine, 177
Leidl, Reiner M. Some Factors to Consider When Using the Results of Economic Evaluation Studies at
the Population Level, 467
Lindgren, Bjorn. See Wallengren
Lindholm, Lars, Gideon Hellsten, and Mans Rosén. Are People Willing to Pay for a Community-Based
Preventive Program?, 317
Lépez-Cervantes, Malaquias. See Martinez-Palomo
Johannesson, Magnus. The Concept of Cost in the Economic Evaluation of Health Care: A Theoretical
Inquiry, 675
Marshall, Deborah. See Menon
Martinez-Palomo, Adolfo, Phyllis Freeman, and Malaquias Lopez-Cervantes. The Role of Vaccine
Research and Development in the Scientific Development of Middle-Income Countries, 30
McGhee, Jerry R., and Hiroshi Kiyono. Effective Mucosal Immunity: Current Concepts for Vaccine
Delivery and Immune Response Analysis, 93
728 INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 10:4, 1994
MEETINGS AND ANNOUNCEMENTS, 205, 334
Mekalanos, John J. Live Attenuated Vaccine Vectors, 131
Menon, Devidas, and Deborah Marshall. Diffusion of Laparoscopic cholecystectomy in Canada, 287
Milstien, Julie B. See Lemon
Moller, Anders. See Larsson
Morrissey, Joseph P. See Kaluzny
Motulsky, Arno G., Frederick C. Robbins, and Thomas H. Murray. Introduction: The New Genetics
and Health Care, 525
Mundinger, Mary. See Neuhauser
Murray, Thomas H. Assessing Genetic Technologies: Two Ethical Issues, 573
Murray, Thomas H. See Motulsky
Nesbitt, Thomas S. See Rosenblatt
Neuhauser, Duncan, and Mary Mundinger. Introduction, 209
Nilsson, Bo. See Tennvall
Nishino, Ruriko, See Kitai
Nishiyama, Mayumi. See Kitai
Nordenskidld, Ulla. Evaluation of Assistive Devices After a Course in Joint Protection, 293
Ochiai, Kazunori, Yoshiteru Terashima, Hiroshi Sasaki, and Masanori Fukushima. Prognostic Factor
Analysis and Treatment Results of Ovarian Cancer, 406
Olivé, Jean-Marc. See de Quadros
Oshima, Akira. A Critical Review of Cancer Screening Programs in Japan, 346
Parker, David, and Terrel Hill. The Contribution of Immunization to Economic Development, 21
Paterson, Neil. See Buckingham
Persson, Ulf. See Tennvall
Pettersson, Gésta. See Larsson
Pichichero, Michael. See Insel
Prescott, Patricia A. Cost-Effective Primary Care Providers: An Important Component of Health Care
Reform, 249
Rabinovich, N. Regina. See La Montagne
Ramachandran, Suryanarayan, and Philip K. Russell. Conclusion: A New Technologic Synthesis: The
Children’s Vaccine Initiative, 193
Ranstam, Jonas. See Wallengren
REVIEWS, 330, 517, 717
Ripich, Stefan. See Brennan
Robbins, Anthony. See Freeman
Robbins, Anthony, and Isao Arita. The Global Capacity for Manufacturing Vaccines: Prospects for
Competition and Collaboration Among Producers in the Next Decade, 39
Robbins, Frederick C. See Motulsky
Rosén, Mans. See Lindholm
Rosenblatt, Roger A., Gregory R. Saunders, Carolyn J. Tressler, Eric H. Larson, Thomas S. Nesbitt,
and L. Gary Hart. The Diffusion of Obstetric Technology into Rural U.S. Hospitals, 479
Rosenau, Pauline Vaillancourt. Reflections on the Cost Consequences of the New Gene Technology for
Health Policy, 546
Rosenqvist, Urban. See Furu
Ross, lain. See Buckingham
Rossiter, Belinda J.F. See Alford
Rowley, Janet D. DNA Diagnosis in Oncology, 644
Russell, lan. See Buckingham
Russell, Philip K. See Ramachandran
Samuelsson, Sven-Marten. See Wallengren
Sasaki, Hiroshi. See Ochiai
Saunders, Gregory R. See Rosenblatt
Sayama, Mitsuko. See Kitai
Seitz, Pauline. See Taft
Shapiro, Peter A. See Larsson
Shimbo, Takuro, John M. Eisenberg, and Henry A. Glick. Cost-effectiveness Analysis of Strategies for
Colorectal Cancer Screening in Japan, 359
Soller, Jerome. See Gillis
Sondik, Edward J. See Kaluzny
Stauning, Inger. Women, Health, and Medical Technology, 273
Stein, Kathryn E., Glycoconjugate Vaccines: What Next? 167
INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 10:4, 1994 729
Index
Stetler, Cheryl B., John Biancamano, John Fagan, Stephen Curry, and Monica Hanson. Patient-Centered
Redesign: More Collaborative Clinical Input into Capital Budget Decisions, 227
Stolz-Léfgren, Marie. See Larsson
Taft, Susan Hoefflinger, and Pauline Seitz. Innovations in Human Service Technologies: Strengthening
Health Care Delivery Systems, 214
TECHNOLOGY ASSESSMENT REPORTS, 197, 198, 200, 202, 203, 325, 326, 327, 328, 710, 711, 713,
714, 715
Tennvall, Gunnel Ragnarson, Ulf Persson, and Bo Nilsson. The Economic Costs of Acute Myeloid
Leukemia in Sweden, 683
Terashima, Yoshiteru. See Ochiai
Tressler, Carolyn J. See Rosenblatt
Tsuchihashi, Nobuaki. See Ikeda
Wallengren, Brita, Bj6rn Lindgren, Jonas Ranstam, Sven-Marten Samuelsson, and Stefan Jendteg. Use
of the Swedish Microcomputer Alarm System in Care for the Elderly and Disabled: Policy and
Practice, 498
Warnecke, Richard. See Kaluzny
Warren, Kenneth S. The Effectiveness of Means of Controlling Communicable Diseases, 14
Watanabe, Hisako. See Kitai
William-Olson, Eva Berglin. See Larsson
Wivel, Nelson A. Gene Therapy: Molecular Medicine of the 1990s, 655
Woodin, Kathleen. See Insel
Wright, David. See Jefferson
YOU ARE CORDIALLY INVITED TO ATTEND
<aTIONAL
guht %V0, THE 11TH ANNUAL ISTAHC MEETING
STOCKHOLM, SWEDEN
x JUNE 4-7, 1995 *
TECHNOLOGY ASSESSMENT IN HEALTH CARE
TOPICS THAT HAVE BEEN PROPOSED:
STOCKHOLM, Oftencalled” The
Venice of the North”, is well ASSESSMENT OF GENE TECHNOLOGY IN HEALTH CARE
known to the scientific world for Man -T°0V 0olol- tele-] Te1l 1 l et
the Nobel Prize. The Swedish
capital, considered to be one of APPLYING CLINICAL RESEARCH TO ASSESSMENT
the world’s most beautiful cities, CONTROVERSIES IN SCREENING
wilbel t he meeting venoufe th e TECHNOLOGY ASSESSMENT AND INDUSTRY
11th annual ISTAHC meeting in
ASSESSING DISEASE PREVENTION
1995. Stockholm is built on 14
islands, making it a perfect ASSESSING CANCER TREATMENTS
location for the yearly interna- * ASSESSING TECHNOLOGY FOR THE HANDICAPPED
tional Water Festival. Beside the
natural beauty of the cityscape,
tourists also appreciate numerous FOR FURTHER INFORMATION PLEASE CONTACT:
historical sights and more than SBU, Box 16158, S-103 24 STOCKHOLM, SWEDEN.
50 museums. TELEPHONE: +46 —- 8 —- 611 19 13. FAX: +46 —- 8 —- 611 79 73.
730 ==I NTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 10:4, 1994